Sunday, June 13, 2021

Rigel Pharmaceuticals Inc. (RIGL) Stock is Soaring, Here is What You Need to Know

Rigel Pharmaceuticals Inc. (RIGL), a biotechnology company specializing to manufacture and commercialize novel molecule drugs, soared 12.14% at $3.46 in current-market trading hours on the last check Tuesday, 13th April. The rise in RIGL stock price came after positive news in regards to a COVID-19 treatment under development.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



RIGL announced positive data from the Phase 2 clinical trial, to evaluate the safety of fostamatinib, which will be used for severe cases of Covid-19 effected hospitalized patients.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


The trials are taking place in partnership with the National Heart, Lung, and Blood Institute, an arm of the National Institutes of Health, as well as Inova Health Systems, with drug evaluation emphasizing safety and minimal side effects. In accordance to RIGL data, there was a reduction of 50% in adverse events after the drug was ingested.

About Rigel Phase 2 clinical data

The trial, met its standard safety endpoint, with a considerable reduction in diseases related to hypoxia. Furthermore, RIGL held a trial consisting of four intubated patients on mechanical ventilation (ordinal scale 7) where two patients were randomly chosen for treatment and two were given placebos. Both patients given drugs produced by Rigel improved within a week and came off the ventilator, while both patients in the placebo group deteriorated in health.

“Fostamatinib was shown to be well tolerated in hospitalized patients with COVID-19 on oxygen. Taken altogether, the results of this trial suggest fostamatinib may be a useful addition to improve the outcome of severe and critically ill COVID-19 patients who are at the highest risk of death despite treatment with the best conventional therapies under the current standard of care (including remdesivir and steroids),” stated Wolfgang Dummer, M.D., Ph.D., Rigel’s Chief Medical Officer, emphasizing upon the significance of this drug’s breakthrough for the pandemic.

Furthermore, The median number of days in the ICU was substantially reduced with RIGL planning for approval of emergency use authorization from the FDA.

Conclusion

RIGL stock has increased dramatically after hitting a positive indication for the development of a drug for extreme covid 19 cases. Furthermore, positive data in regards to treatment as well as a potential for FDA approval has skyrocketed the stock immensely and peaked investor interest.

Latest news

 Hawaiian Holdings Inc. (HA): Weak Share Price A Buying Opportunity

Travel restrictions continue to be eased by Hawaii for tourists. Consequently, Hawaiian Airlines, owned by Hawaiian Holdings Inc. (NASDAQ: HA), stands to benefit as...

Set Your Sights On Conn’s Inc. (NASDAQ: CONN)’S Upside Potential

A furniture and home furnishings retailer, Conn's Inc. (NASDAQ: CONN), reported growth in sales in the first quarter. The company's performance surpassed analysts' predictions...

Does Investing In Roblox Corporation (RBLX) A Smart Move?

Roblox Corp. (NYSE: RBLX) released its first-quarter earnings report earlier this week. Growth in earnings and subscriber numbers are the main driving forces of...

Why is Sea Limited (SE) stock increasing rapidly?

Sea Limited (NYSE: SE), an online gaming, e-commerce, and digital payments company, reported strong earnings in the first quarter of 2021. Company revenue growth...

Related news

 Hawaiian Holdings Inc. (HA): Weak Share Price A Buying Opportunity

Travel restrictions continue to be eased by Hawaii for tourists. Consequently, Hawaiian Airlines, owned by Hawaiian Holdings Inc. (NASDAQ: HA), stands to benefit as...

Set Your Sights On Conn’s Inc. (NASDAQ: CONN)’S Upside Potential

A furniture and home furnishings retailer, Conn's Inc. (NASDAQ: CONN), reported growth in sales in the first quarter. The company's performance surpassed analysts' predictions...

Does Investing In Roblox Corporation (RBLX) A Smart Move?

Roblox Corp. (NYSE: RBLX) released its first-quarter earnings report earlier this week. Growth in earnings and subscriber numbers are the main driving forces of...

Why is Sea Limited (SE) stock increasing rapidly?

Sea Limited (NYSE: SE), an online gaming, e-commerce, and digital payments company, reported strong earnings in the first quarter of 2021. Company revenue growth...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.